Cargando…
THU662 Poor Response To Medical Treatment In A Patient With Amiodarone-induced Hyperthyroidism: A Therapeutic Dilemma
Disclosure: A.A. Asiri: None. R. Sulimani: None. W. Alkhidady: None. Introduction: Hyperthyroidism is a well-known complication of amiodarone therapy. An incidence of 3% is reported in North America(1), and even higher percentages in amiodarone deplete areas of about 10%.(2) Treatment of amiodarone-...
Autores principales: | Ahmed Asiri, Alanood, Sulimani, Riad, Alkhidady, Wijdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554925/ http://dx.doi.org/10.1210/jendso/bvad114.1785 |
Ejemplares similares
-
THU668 Euthyroid Graves’ Ophthalmopathy: Case Series
por: Saleh Alfadl, Sultan, et al.
Publicado: (2023) -
THU654 The Use Of Plasmapheresis In A Severe Case Of Amiodarone Induced Thyrotoxicosis
por: Moazezi, Tina, et al.
Publicado: (2023) -
THU661 Marine-Lenhart Syndrome: An Unusual Presentation Of Hyperthyroid Disease
por: Ji, Beisi, et al.
Publicado: (2023) -
THU659 Plasmapheresis As A Therapy For Amiodarone-induced Thyrotoxicosis: A Case Report And Literature Review
por: Loughner, Chelsea L, et al.
Publicado: (2023) -
THU657 Racing Hearts: A Closer Look At The Connection Between Hyperthyroidism And Coronary Vasospasm
por: Elahi, Amna, et al.
Publicado: (2023)